BBS

Clinical Trial

NCT03490019 Inactive

BBS

Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a PossibleVisual Improvement.

Phase 2

Interventional

Disease

Disease type

Bardet-Biedl

Hereditary retinal disease

Paediatric clinical trials

Retinitis Pigmentosa

Orphan drug recognition

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

01/04/2018

Closing date

01/08/2020

Inclusion criteria :

Exclusion criteria :

Funding

national institution

Members involved

Main investigators

Heiko Billing

Germany

ERN EYE member investigating site

HCP : Principal investigators

Centre for Ophthalmology, University Eye Hospital, Tübingen, Germany

Adress

Department für Augenheilkunde Tübingen Forschungsinstitut für Augenheilkunde Elfriede-Aulhorn-Str. 7

72076 Tübingen

Germany

Contact

07071 29-84021

Website

See full page

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Accessibility

BBS

In this page